{"Title": "Trial endpoints for systemic therapy in patients with hepatocellular carcinoma", "Year": 2019, "Source": "J. Hepatol.", "Volume": "70", "Issue": 6, "Art.No": null, "PageStart": 1060, "PageEnd": 1061, "CitedBy": 0, "DOI": "10.1016/j.jhep.2019.03.001", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85064995845&origin=inward", "Abstract": null, "AuthorKeywords": null, "IndexKeywords": ["Carcinoma, Hepatocellular", "Humans", "Liver Neoplasms", "Randomized Controlled Trials as Topic"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 1, "EID": "2-s2.0-85064995845", "SubjectAreas": [["Hepatology", "MEDI", "2721"]], "AuthorData": {"57199899475": {"Name": "Meyer T.", "AuthorID": "57199899475", "AffiliationID": "60109234, 60022148", "AffiliationName": "Department of Oncology, UCL Cancer Institute, University College London"}, "7405661637": {"Name": "Johnson P.", "AuthorID": "7405661637", "AffiliationID": "60020661", "AffiliationName": "Department of Molecular and Clinical Cancer Medicine, University of Liverpool"}}}